RVG29‐modified docetaxel‐loaded nanoparticles for brain‐targeted glioma therapy
Sign Up to like & getrecommendations! Published in 2018 at "International Journal of Pharmaceutics"
DOI: 10.1016/j.ijpharm.2018.03.028
Abstract: &NA; Gliomas are the most common malignant brain tumor, but treatment is limited by the blood–brain barrier (BBB), especially for chemotherapeutic drugs. Although some chemotherapy drugs can pass through the BBB, many of these agents… read more here.
Keywords: rvg29 modified; brain; glioma therapy;
Pseudoprogression after glioma therapy: an update
Sign Up to like & getrecommendations! Published in 2017 at "Expert Review of Neurotherapeutics"
DOI: 10.1080/14737175.2017.1375405
Abstract: ABSTRACT Introduction: Initial diagnostics and follow-up of gliomas is usually based on contrast-enhanced MRI. However, the capacity of standard MRI to differentiate neoplastic tissue from posttherapeutic effects such as pseudoprogression is limited. Advanced neuroimaging methods… read more here.
Keywords: pseudoprogression; glioma therapy; pwi; pseudoprogression glioma ... See more keywords
Filamentous Bacteriophage—A Powerful Carrier for Glioma Therapy
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.729336
Abstract: Glioma is a life-threatening malignant tumor. Resistance to traditional treatments and tumor recurrence present major challenges in treating and managing this disease, consequently, new therapeutic strategies must be developed. Crossing the blood-brain barrier (BBB) is… read more here.
Keywords: bacteriophage powerful; glioma therapy; filamentous bacteriophage; glioma ... See more keywords